Alozairi, E., Taghadom, E.
, Irshad, M., Al Yousef, A., Alkandari, J., Al-Najim, W., Alabdulkader, S., Miras, A. D., & le Roux, C. W. (2024).
combining glp-1 with sglt2 inhibitors to treat patients with type 1 diabetes, bmi more than 25 kg/m2, and chronic kidney disease: a randomised, controlled trial.
Diabetologia,
67, S519-S520.